<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>All About MS &#187; Rituximab</title>
	<atom:link href="http://allaboutms.ca/category/research/rituximab/feed/" rel="self" type="application/rss+xml" />
	<link>http://allaboutms.ca</link>
	<description>MS Information and Research</description>
	<lastBuildDate>Tue, 07 Sep 2010 14:11:49 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Study to compare Avonex plus a placebo to Ocrelizumab</title>
		<link>http://allaboutms.ca/2009/02/27/1051/</link>
		<comments>http://allaboutms.ca/2009/02/27/1051/#comments</comments>
		<pubDate>Sat, 28 Feb 2009 03:24:13 +0000</pubDate>
		<dc:creator>Bonnie</dc:creator>
				<category><![CDATA[Rituximab]]></category>
		<category><![CDATA[Avonex]]></category>
		<category><![CDATA[drug trial]]></category>
		<category><![CDATA[lesions]]></category>
		<category><![CDATA[MRI]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[multiple sclerosis]]></category>
		<category><![CDATA[ocrelizumab]]></category>
		<category><![CDATA[Phase II Study]]></category>
		<category><![CDATA[placebo]]></category>
		<category><![CDATA[relapsin remitting multiple sclerosis]]></category>
		<category><![CDATA[trial]]></category>

		<guid isPermaLink="false">http://allaboutms.ca/?p=1051</guid>
		<description><![CDATA[A randomized, placebo and active-controlled dose finding study to evaluate the efficacy, as measured by brain MRI lesions, and safety of 2 dose regimens of ocrelizumab in patients 

]]></description>
		<wfw:commentRss>http://allaboutms.ca/2009/02/27/1051/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
